Trinity Biotech | TRIB - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.06B 69M 2026-03
Bayer EUR 25.95B 3.75B 2025-12
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
EDAP TMS EUR 23.32M 4.5M 2025-09
J&J USD 81.19B 358M 2026-03
Mesa Laboratories USD 186.69M 8.22M 2025-12
OraSure Technologies USD 340.83M 21.15M 2025-12
Plus Therapeutics USD 4M 1.06M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Siemens EUR 65.48B 3.24B 2025-12
Surmodics USD 111.31M 7.59M 2025-06
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Tosoh JPY 803.3B 7.06B 2025-12
Trinity Biotech USD -54.72M 5.18M 2025-09
Veracyte USD 1.34B 34.83M 2026-03